A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes

NCT04864977 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was stopped prior to study start date due to business decision.

Conditions

Type 2 Diabetes
Type 2 Diabetes Treated With Insulin

Interventions

DRUG: Basal Insulin

Sponsor

Eli Lilly and Company